Related Experiment Videos
[A study on bone metabolism in woman with hyperprolactinemia]
T Fujimaki1, T Kurabayashi, T Ootani
1Department of Obstetrics and Gynecology, Niigata University School of Medicine.
Nihon Sanka Fujinka Gakkai Zasshi
|May 1, 1994
Summary
Hyperprolactinemia is linked to lower bone mineral density (BMD) in women, with longer disease duration worsening bone loss. Increased bone turnover suggests prolactin may directly impact bone health.
Area of Science:
- Endocrinology
- Bone Metabolism
- Reproductive Health
Context:
- Hyperprolactinemia, a condition of elevated prolactin levels, affects bone metabolism.
- Understanding the impact of hyperprolactinemia on bone mineral density (BMD) is crucial for managing associated health risks.
Purpose:
- To investigate the relationship between hyperprolactinemia and bone mineral density (BMD).
- To analyze bone metabolic parameters in hyperprolactinemic women compared to healthy controls.
Summary:
- This study compared BMD in 21 hyperprolactinemic women with 57 normal subjects using dual-energy X-ray absorptiometry (DXA).
- Hyperprolactinemic women exhibited significantly lower mean BMD (0.940 g/cm2) than controls (1.030 g/cm2), a 9% reduction (p < 0.05).
- A negative correlation between BMD and hyperprolactinemia duration was observed, alongside increased bone turnover, formation, and absorption markers.
Impact:
- Findings suggest hyperprolactinemia negatively impacts bone health, likely through hypoestrogenemia and potentially direct prolactin effects.
- This research highlights the need for monitoring bone health in individuals with hyperprolactinemia.